According to the KEGG pathway enrichment analysis results (Figures 2c, d), Western blot analysis was used to detect changes in the FAK/PI3K/AKT/GSK3β/β-catenin signaling pathway in BMSCs from T2DM patients after 7 days of osteogenic induction. This evidence concerns the gene GSK3B and type 2 diabetes mellitus.